Perspectives: Drugmakers Hike Prices Because They Can. The How Gets A Little More Complicated.
Read recent commentaries about drug-cost issues.
Archives: Morning Breakouts
34,441 - 34,460 of 112,520 Results
-
-
Next Up On The Pharma Rebranding Bandwagon: Generics
News outlets report on stories related to pharmaceutical drug pricing.
By brilabuskes -
State Highlights: Ga.’s ‘Surprise’ Medical Bill Legislation Hits Snag; Mass. Commission Urges State To Up Oversight Of Hospital Rates
Outlets report on news from Georgia, Massachusetts, Minnesota, Connecticut, Texas, Michigan, Kansas, California, Maine and Florida.
By brilabuskes -
Central Illinois Facing Adequacy ‘Crisis’ As Hospitals Reject Medicaid Managed Care Plans
At least three hospital systems have announced plans to cut ties with Molina Healthcare, which manages the state's Medicaid program in central Illinois, leaving tens of thousands of enrollees in a tough position. Also, legislators in Colorado begin to explore how to cover the expanding Medicaid budget.
By khnlexiev -
Public Education, Increased PrEP Use Credited For Big Drop In HIV Rates
Overall the numbers are improving, but some groups have double-digit increases.
By brilabuskes -
In Effort To Stem Flood Of Opioids Into Country, Bill Would Tighten Up International Shipping Rules
The legislation would require packages shipped into the United States from foreign postal services and through the U.S. Postal Service to provide information on who is sending the package, where they are sending it from, who it’s being sent to, and what the package contains.
By brilabuskes -
Advisory Panel, Tiptoeing Into Ethical Minefield, Reverses Guidance On Editing Human Embryos
The National Academy of Sciences and the National Academy of Medicine said that modifying genes in embryos is acceptable if the alterations are designed to prevent babies from acquiring genes known to cause “serious diseases and disability,” and only when there is no “reasonable alternative.”
By brilabuskes -
Decades-Long Quest To Battle Alzheimer’s Dealt Latest Blow As Merck Pulls Plug On Anticipated Drug
Similar treatments from Eli Lilly, Pfizer and Johnson & Johnson have all come up short in recent years. Meanwhile, treatments for mental illnesses have seen few advances despite increased understanding of the diseases.
By brilabuskes -
GOP Bill Would Roll Back Obama’s Ban On States Defunding Planned Parenthood
Because the measure, which was sent to the House floor on Tuesday, is being moved through a law that allows Congress to rescind recently finalized rules, the bill cannot be filibustered in the Senate, raising its odds for success. Media outlets report on women's health news out of Oklahoma, Texas and Arkansas as well.
By brilabuskes -
AP Finds Potential Conflict Of Interest Issues Around CMS Nominee Seema Verma’s Work In Indiana
In a review of documents, The Associated Press reports that Verma's consulting firm made millions through agreements with nine states -- work that may have conflicted with her public duties. And KHN reports on the reemergence of "death panel" fears.
By brilabuskes -
Math For Insurance Only Adds Up If Healthy Subsidize The Sick, Expert Says
Economist Jonathan Gruber, who worked on both the Massachusetts and federal health overhauls, joined other health experts on a panel looking at the obstacles Republicans will face when trying to craft something that's less expensive but still ensures people have access to coverage. Meanwhile, actuaries offer their take on stabilizing the marketplace.
By brilabuskes -
Uninsured Rate Lowest On Record As Republicans Prepare To Dismantle Health law
The rate of uninsured in America is nearly half what it was before the Affordable Care Act was passed.
By brilabuskes -
House Republicans Weighing Key Medicaid Change As Part Of Health Law Overhaul
Rep. Brett Guthrie, R-Ky., says Republican leaders are considering switching federal payments for Medicaid to per capita allotments, but it's not clear that proposal will win supporters in the Senate. Meanwhile, Politico looks at how GOP lawmakers who want to cut Medicaid spending may be forced to increase the funding for a bit.
By brilabuskes -
As Conservatives Dig In On Complete Repeal, GOP Leaders Warily Eye Growing Intra-Party Divide
The Freedom Caucus vows to block any legislation that doesn't go far enough. Meanwhile, Speaker Paul Ryan is making the rounds to try to gin up support.
By brilabuskes -
Near-Simultaneous Deaths Of Two Insurance Mega-Mergers Signals Victory For Antitrust Officials
Within hours of each other, companies involved in the Aetna-Humana merger and the Cigna-Anthem deal threw in the towel.
By brilabuskes -
Humana First Insurer To Quit ACA Marketplaces Amid Uncertainty Of Health Law’s Future
President Trump and other opponents see the decision as a sign that the Affordable Care Act is failing, but many insurers cite the murkiness of the Republicans' plan for dismantling the legislation as a reason to be skittish about the marketplaces.
By brilabuskes -
First Edition: February 15, 2017
Today's early morning highlights from the major news organizations.
By brilabuskes -
After Defeat In Court, Aetna And Humana Announce They Will End Their Effort To Merge
A federal court judge ruled last month that the $34 billion merger would hurt competition in the insurance industry. As part of the deal, Aetna will give Humana $1 billion as a break-up fee,
By khnlexiev -
Viewpoints: Connecting Executive Pay With Patients; Is Technology Driving Up Health Costs
A selection of opinions on health care from around the country.
-
Different Takes On The Complications Of Replacing Obamacare
Opinion writers offer their thoughts on the possible landmines involved in replacing or repairing the health law, including what voters have to gain and lose as well as what costs could result.